WebSep 19, 2006 · About Vivos Inc. (OTC: RDGL) Currently, the Company has developed an Yttrium-90 based brachytherapy device, for the treatment of tumors in animals and … WebPress Releases - RadioGel™ (OTCMKTS:RDGL) Press Releases Vivos Inc Files a New Patent on the Hydrogel Component of IsoPet®/RadioGel (TM) 9/14/22 6:30 Vivos Inc. Announces a New IsoPet® Precision Radionuclide Therapy Regional Clinic for Equine Therapy 8/16/22 6:30 Vivos Inc. Provides Intellectual Property Protection Update 5/12/22 6:30
Rigel Pharmaceuticals (RIGL) Stock Price Today, News, Quotes, …
WebApr 15, 2024 · Posted by Defense World Staff on Apr 15th, 2024. Vivos Inc. ( OTCMKTS:RDGL – Get Rating) was the target of a significant growth in short interest in the month of March. As of March 31st, there ... WebMar 28, 2024 · RDGL 0.0027 4.27% Mar 28, 2024 3:59 p.m. EDT Real Time Quote About Vivos Inc. Vivos, Inc. is a radiation oncology medical device company. It is engaged in the development of its yttrium-90... grailed app not working
Vivos Inc (RDGL) Stock Price & News - Google Finance
WebVivos Inc. RDGL (U.S.: OTC) View All companies AT CLOSE 3:59 PM EDT 03/17/23 $0.063 USD 0.0032 5.35% Volume 361,296 65 Day Avg Vol 470,857 1 Day Range 0.057 - 0.0639 52 Week Range 0.04 - 0.1264... WebVivos Inc (RDGL) Company Description. Vivos Inc is a radiation oncology medical device company. It is engaged in the development of RadioGel which is a brachytherapy device comprising highly insoluble particles delivered by needle injection using a water-polymer composite for high-dose treatment of non-resectable solid tumors. WebApr 15, 2024 · Posted by MarketBeat News on Apr 15th, 2024 Vivos Inc. ( OTCMKTS:RDGL – Get Rating) was the target of a significant increase in short interest in March. As of March … china-lac business summit